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ABSTRACT 
Despite 4 decades’ effort, an effective HIV-1 vaccine has not been produced owing to the 
inevitable antigenic diversity of the virus and millions of people around the world have lost their lives 
due to HIV. Increasing the knowledge of adaptive immune response to vaccination would ultimately 
lead to an effective HIV cure. Antibodies, which are responsible for protection and fighting against 
antigens, are vital parts of immune system response. In order to identify discriminative antibodies, which 
provide protection against HIV, and to disclose the associations between antibody features and their 
functional outcomes, computational methods, such as feature selection, regression and classification 
can be used to construct predictive models. Here we used our unsupervised K-Means Based Feature 
Selection (KBFS) method which is presented in our previous study, to identify functional antibodies that 
fight against HIV. The accuracy results for the proposed KBFS framework are compared with those 
presented in a recent study and are also compared with results from four different state-of-the-art 
unsupervised feature selection methods, namely MCFS, InFS, LapFS, and SPFS, along with the entire 
feature set. Then, support vector based systems are utilised to predict the associations between antibody 
features and their functional activities, namely gp120-specific antibody dependent cellular phagocytosis 
(ADCP), antibody dependent cellular cytotoxicity (ADCC) and cytokine release activities on RV144 
vaccine recipients. Pearson Correlation Coefficient (PCC) metric is used to evaluate the prediction 
accuracy of the predictive models and to be consistent with the previous study. Our SVR based KBFS 
framework presented higher accuracy than the original study by improving prediction performance 16% 
for ADCP assay, 200% for the ADCC assay.  
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1. INTRODUCTION 
Antibodies are specialised Y-shaped glycoproteins (gp) that are produced by plasma 
cells to defend against intruders that cause infection. Antibodies are crucial for the immune 
system since they play a role in protecting against foreign substances or antigens. Antibodies 
consist of two antigen-binding fragments: fragment antigen-binding (Fab) and fragment 
crystallisable (Fc). Fab regions are the arms of the antibodies called immunoglobulin G (IgG) 
which are responsible for the identification of infected cells [1]. On the other hand, Fc regions 
stimulate the innate immune system to neutralise antigens. Antigens that exist in vaccines 
stimulate immune system response by instructing B-cells in order to produce antibodies which 
are responsible for protection. Vaccine-induced immunity effectors, or antibodies, are 
important defenders against antigens, including HIV viruses. Vaccination provides active 
protection since it trains the immune system to recognise antigens. Then, the immune system 
produces specific antibodies to fight against the antigens. The function of antibodies is to 
recognise and bind to antigens. This detection process begins when antibodies recognise a small 
region on the surface of an antigen called the epitope [2]. Vaccine-mediated antibodies are 
important defenders against intruders including Human Immunodeficiency Virus (HIV) [3]. 
HIV attacks and destroys the immune system; indeed, it causes depletion of CD4-positive 
lymphocytes. The RNA of HIV has only nine genes that contain the code necessary to produce 
structural enzymes [5]. HIV poses a number of immunological threats to the human immune 
system due to its extensive genetic diversity. Furthermore, HIV is capable of developing 
countermeasures to avoid the effect of antibodies. HIV can prevent itself from being detected 
by the immune system thanks to its reverse transcription ability. This ability enables HIV to 
mutate approximately 3x105 per nucleotide base [6]. Therefore, producing an effective 
vaccine which can elicit antibodies to block HIV is vital to neutralise the virus [7]. Novel 
vaccine strategies are required to overcome the aforementioned challenges posed by HIV. 
Increasing the knowledge of associations between virus and immune system would ultimately 
result in producing an effective vaccine; an example is RV144. Functional antibodies are 
considered to be HIV inhibitors [8]. These inhibitory antibodies are capable of binding to 
virions, reducing their movement across mucus and mediating a variety of Fc receptor-mediated 
anti-HIV-1 activities, such as Antibody Dependent Cellular Cytotoxicity (ADCC) [9] [10]. 
ADCC-mediated antibodies can eradicate HIV infected CD4 cells [11] and block the 
transmission of HIV within 24 hours after viral entry [12].  
Vaccination is a provider of active immunity since it stimulates the immune system to 
produce antibodies which fight against a virus. Interestingly, specific antibodies provide 
protection against specific antigens [13]. More- over, the amounts of antibodies that are 
produced by the immune system are statistically related to the protection given, since antibodies 
will be needed for the subsequent attacks from antigens [14]. The functional characteristics of 
antibodies are also crucial for HIV protection; therefore, the identification of specific antibodies 
that mediate effector functions to neutralise HIV is essential for producing an effective HIV 
vaccine. Antibodies can also collaborate with other functions to provide prevention against 
viruses [15] [16]. Therefore, the identification of discriminative antibody features is crucial in 
producing prevention against HIV.  
2. METHODS AND MATERIAL 
In this section methods and materials which are used in this study is presented. 
2.1. The Dataset 
The RV144 data set provided in [1] is utilised in this study to model their antibody 
feature function relationships and to disclose HIV-specific antibodies. This data set contains 
 SARAÇ / A Support Vector-Based Predictive Model to Reveal the Relationships among Antibody 
Features and their Effective Functions against HIV 
Journal of Scientific Perspectives, Volume:3, Issue:4, Year:2019 
263 
100 plasma samples (20 of them are placebo and 80 of them are vaccine injected) obtained from 
the individuals who participated in the RV144 vaccine trial at week 26.  
Three different cell-mediated assays are used in this thesis: Antibody Dependent 
Cellular Phagocytosis (ADCP), Antibody Dependent Cellular Cytotoxicity (ADCC), and 
Natural Killer Cell Cytokine release. ADCC antibodies are capable of identifying infected cells, 
and these antibodies are involved in the binding of epitopes of HIV-infected cells [18]. 
Cytotoxicity activities are mediated by Natural Killer (NK) cells which can directly kill virally 
infected cells by adhering to them. Cytokine release activities includes the NK cell surface 
expression of CD107a and the quantitative detection of MIP-1-β and IFN-γ levels produced 
inside the cell. An anti- gen microsphere based liquid array is applied to determine antibodies 
(gp41, gp140, p24, gp120, and V1V2) and subclasses (IgG1, IgG2, IgG3, IgG4).  
HIV-1 vaccine injection has been shown to be less effective due to the intrinsic 
variability of the virus. The identification of distinctive antibodies which correlate with 
protection against HIV-1 infection, along with increasing the knowledge of associations 
between immune mechanisms and HIV, would ultimately result in the development an effective 
vaccine against HIV.  
In this study, three different cell-mediated assays, ADCC, ADCP, and Cytokine re- 
lease, are used. The purposes of exploiting the RV144 data set are: (i) to differentiate functional 
antibodies; (ii) to identify the relationships between the human immune system and the HIV 
virus; and (iii) to test the effectiveness of the DFSFR framework for the given data set. The aim 
of this study is, therefore, to predict functional relationships between antibody features and their 
functional activities in RV144 vaccine recipients. Each data sample has twenty antibody 
features that consist of features related to IgG subclass and antigen specificity.  
2.2. Feature Selection Methods 
Four different feature selection methods along with the entire feature set are used to 
identify discriminative antibody features from RV144 dataset.  
2.2.1. K-Means Based Feature Selection (KBFS)  
KBFS is proposed in our previous study [19] and applied to a high dimensional age 
dataset. Here we adapted this method to disclose the relationship among antibody features and 
HIV. 
At the first stage of KBFS, the data is transposed in order that samples become features 
and features become samples. The reason for this is to ensure that instead of samples the features 
are clustered in k-means algorithm. Next, based on user-specified integer (k), the data will be 
divided into k- clusters. The K-means clustering algorithm sorts the features based on their 
distance from the centroids in each cluster, and it usually exploits Euclidean or squared 
Euclidean distance measure. On the other hand, KBFS identifies three centroids based on their 
distance to the center of each cluster. The purposes of this is to minimise randomisation error 
and to deal with outliers.  
Euclidean distance which is the most commonly used distance metric is exploited to 
calculate the distances among centroids and features. Euclidean distance can be calculated 
from:  
𝐽 = ∑ ∑ ||𝑥𝑖 − 𝐶𝑗||
2
𝑛
𝑖=1
𝐾
𝑗=1
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where 𝑥𝑖𝑠 𝑖 = 1,2, … , 𝑛 are a set of features to be partitioned to K clusters and 𝐶𝑗𝑠 𝑗 =
1,2, … , 𝐾 
are the centroid points. 
In KBFS, three centroid points are exploited for each cluster and features are ranked 
based on their absolute distance values to those centroids. A feature with the lowest distance to 
the any of three centroid points in a cluster is considered as the most important one. In KBFS, 
distance measure is calculated by: 
𝐽𝑖1 = ∑ ∑ ||𝑥𝑖 − 𝐶𝑗1||
2
𝑛
𝑖=1
𝐾
𝑗=1
 
𝐽𝑖2 = ∑ ∑ ||𝑥𝑖 − 𝐶𝑗2||
2
𝑛
𝑖=1
𝐾
𝑗=1
 
𝐽𝑖3 = ∑ ∑ ||𝑥𝑖 − 𝐶𝑗3||
2
𝑛
𝑖=1
𝐾
𝑗=1
 
The weight of a feature is then calculated by:  
𝑊𝑋𝑖 =
1
min  (𝐽𝑖1, 𝐽𝑖2, 𝐽𝑖3)
 
The K-means method randomly initialises the centroids and this might profoundly affect 
the clustering results. Therefore, the process of KBFS is repeated 100 times to minimise the 
randomisation error. At the end, the mean of the distances between the centroids and the features 
are calculated in order to rank features. Therefore,  
1
𝑊𝑋𝑖
=
1
𝑝
∑ min (
𝑝
𝑡=1
∑ ∑ ||𝑥𝑖 − 𝐶𝑗1||
2
𝑛
𝑖=1
𝐾
𝑗=1
, ∑ ∑ ||𝑥𝑖 − 𝐶𝑗2||
2, ∑ ∑ ||𝑥𝑖 − 𝐶𝑗3||
2
𝑛
𝑖=1
𝐾
𝑗=1
𝑛
𝑖=1
𝐾
𝑗=1
) 
where 𝑝 = 1,2, … ,100, C represents clusters, 𝑥𝑖𝑠 are features where 𝑖 = 1,2, … , 𝑛, K is 
the number of clusters, W𝑋𝐼 is the weight of i-th feature and 𝐶𝑗𝑠 are centroids. 
2.2.2 Multi-Cluster Feature Selection (MCFS)  
MCFS is a clustering based feature selection method that utilises sparse learning 
technique to select relevant features. MCFS uses spectral analysis to measure the correlation 
between different features.  
2.2.3 Laplacian Score Feature Selection (LapFS) 
LapFS is a graph based unsupervised feature selection method that selects features 
which are important to preserve the data manifold structure. LapFS utilises pairwise similarities 
between features that are measured by using the heat kernel. 
2.2.4 Spectral Feature Selection (SPFS) 
 SPFS can be defined as an extension of LapFS, however, SPFS works for both 
supervised and unsupervised scenarios. SPFS selects features which are consistent with the 
graph structure of the data; however, unlike LapFS, SPFS also independently evaluates features.  
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2.2.5 Infinite Feature Selection (InFS) 
In InFS, each node feature represented with a node in a graph and features are selected 
according to their centrality score. 
2.3. Support Vector Regression  
Support Vector Machine (SVM) is a powerful statistical supervised learning model 
which has been exploited for both regression and classification tasks [24] [25]. In classification 
scenario, SVM realises a discriminative hyperline which achieves the largest margin between 
two classes [25]. The hyperline can be formulated as: 
𝑓(𝑥) = 𝑤 ∗ 𝑥 + 𝑏 
where w is normal to hyperline and 
𝑏
 ||𝑤||2
 is the perpendicular distance from is the 
perpendicular distance from hyperline to the origin. The regression version of SVM is called 
Support Vector Regression (SVR).  
SVR constructs a model function which indicates relationship between features and the 
target variable. In SVR, ε-intensive loss function is used so that only features out of ε tolerance 
are penalised given by: 
𝐶 ∑ ζ𝑝
𝑛
𝑖
 
where p is a positive integer, and ζ is the orthogonal distance away from the ε-region.  
In this study, SVR is implemented with radial basis kernel using the LIBSVM library [26].  
2.4. Performance Evaluation Metrics  
In this study, Pearson Correlation Coefficient metric is used to evaluate the effectiveness 
of predictive models and to compare our results with previous study [1]. 
PCC is an evaluation metric that is exploited to assess the performance of predictive 
models. The PCC evaluates the strength of the relationship between two variables. It can be 
calculated as:  
𝑃𝐶𝐶 =
{𝑛𝛴{𝑥𝑖𝑦𝑖} − 𝛴{𝑥𝑖}𝛴{𝑦𝑖}}
√𝛴𝑥𝑖
2 − (𝛴𝑥𝑖2) √𝛴𝑦𝑖
2 − (𝛴𝑦𝑖2)
 
where x and y are vales the two quantitative variables and PCC indicates the linear 
association between them. A value of PCC that is equal to 1 indicates a perfect linear 
correlation. 
 3. RESULTS AND DISCUSSION 
The RV144 data set provided in [1] is used in this study to model the antibody feature-
function relationship. This data set contains 100 plasma samples (20 of which are placebo and 
80 are vaccine-injected) obtained from the individuals participating in the RV144 vaccine trial 
at week 26. Three different cell-mediated assays are used: Antibody Dependent Cellular 
Phagocytosis; Antibody Dependent Cellular Cytotoxicity; and Natural Killer Cell Cytokine 
Release activities. The accuracy results for the proposed KBFS framework are compared with 
those presented in a previous study [1], and are also compared with results from four different 
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state-of-the-art unsupervised feature selection methods, namely MCFS, InFS, LapFS, and 
SPFS, along with the entire feature set. In this study, the PCC metric is used to be able to 
perform a consistent comparison with the previous study [1].  
The SVR-based predictive models for the regression tasks are constructed using feature 
selection methods (filtered feature set). Their performance is then evaluated using a five-fold 
cross validation method. The RV144 data set is divided into two sets of samples. Four out of 
five samples, with a total of 64 samples, are utilised for training and the rest (16 samples) for 
testing purposes. This process is repeated 200 times by randomly creating subsets of the 
samples for the five-fold cross validation in order to avoid a bias towards and to assess the 
effect of randomisation in the cross validation. At the end, the mean performance and its 
corresponding standard deviation (std) values are obtained for each of the predictive models.  
The prediction performance of unsupervised feature selection methods on three cell-
mediated assays are summarised in Tables 1-3. Table 1 shows the PCC results of predictive 
models for Natural Killer Cell Cytokine release activities. The predictive models aim to 
estimate the level of cytokine release in order to understand its functionality for protection. The 
results suggest that KBFS outperforms state-of-the-art methods with 0.52 PCC using 16 
features. SPEC yields the second-best result yielding 0.51 PCC, with 16 antibody features. 
Other methods produce average results.  
The prediction results of unsupervised predictive models for ADCC activities are 
presented in Table 2. KBFS again produces the best result yielding 0.42 PCC using only 10 
antibody feature. InFS produces the second-best result with 0.40 PCC utilising 14 antibody 
features. Other methods produce average results.  
Table 1. Comparison of Unsupervised Feature Selection Methods for the Antibody Features 
and Natural Killer Cell Cytokine Release Activity Relationship 
Metrics  PCC  
KBFS (16)  0.52 ± 0.17  
MCFS (16)  0.49 ± 0.17  
Laplacian (16)  0.49 ± 0.18  
SPEC (16)  0.51 ± 0.17  
InFS (18)  0.49 ± 0.17  
Baseline (20)  0.49 ± 0.17  
Table 2. Comparison of Unsupervised Feature Selection Methods for the Antibody Features 
and Cellular Cytotoxic Activity Relationship 
Metrics  PCC  
KBFS(11)  0.43 ± 0.19  
MCFS (18)  0.39 ± 0.18  
Laplacian (12)  0.39 ± 0.18  
SPEC (18)  0.41 ± 0.18  
InFS (14)  0.40 ± 0.17  
Baseline(20)  0.38 ± 0.18  
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Table 3. Comparison of Unsupervised Feature Selection Methods for the Antibody Features 
and Cellular Phagocytosis Activity Relationship  
Metrics  PCC  
KBFS(12)  0.65 ± 0.17  
MCFS (17)  0.65 ± 0.14  
Laplacian (3)  0.65 ± 0.15  
SPEC (18)  0.61 ± 0.14  
InFS (18)  0.64 ± 0.15  
Baseline(20)  0.61 ± 0.15  
Table 3 presents the prediction results of USFSMs for ADCP activities. As can be 
clearly seen in the table, KBFS filtered predictive model outperforms the predictive models 
implemented with the complete feature set, InFS and SPEC. On the other hand, KBFS, 
Laplacian Score and MCFS produce the same PCC results with 12, 3 and 17 antibody features 
respectively. 
The prediction results of the proposed method are also compared with those of the 
previous study [1] where the same data set by using the same cross validation method is utilised 
(5-fold with 200 replicates) and comparison results are shown in Tables 4-6. The results appear 
to suggest that KBFS has a better quantitative accuracy than the predictive models constructed 
using Lars, GP and SVR as presented in the previous study for ADCC and ADCP assays, at 
0.43 and 0.65 PCC respectively. In particular, the proposed approach yields as much as 1.16x 
and 3x better outcomes than the results of SVR for the ADCP and ADCC assays respectively. 
KBFS has slightly lower quantitative performance as compared to the predictive model for the 
Cytokine assay constructed using SVR as presented in the previous study. However, it still has 
better quantitative performance than the Lars and GP predictive models for the Cytokine assay.  
Overall, the proposed KBFS method generally achieves the best performance on all cell-
mediated assays, which thereby verifies that it is able to select informative antibody features. 
Table 4. A Comparison of the Results with the Previous Study for the Antibody Features and 
Cellular Phagocytosis Activity Relationship 
Regression  PCC  
Lars [1]  0.61±0.15  
GP [1]  0.53±0.16  
SVR [1]  0.56±0.19  
KBFS  0.65 ±0.17  
Table 5. A Comparison of the Results with the Previous Study for the Antibody Features and 
Cellular Cytotoxic Activity Relationship  
Regression  PCC  
Lars [1]  0.42±0.18  
GP [1]  0.24±0.21  
SVR [1]  0.14±0.24  
KBFS  0.43±0.19  
 SARAÇ / A Support Vector-Based Predictive Model to Reveal the Relationships among Antibody 
Features and their Effective Functions against HIV 
Journal of Scientific Perspectives, Volume:3, Issue:4, Year:2019 
268 
Table 6. A Comparison of the Results with Previous Study for the Antibody Features and 
Natural Killer Cell Cytokine Release Activity Relationship  
Regression  PCC  
Lars [1]  0.51±0.21  
GP [1]  0.46±0.24  
SVR [1]  0.55± 0.15  
KBFS  0.52±0.17  
4. CONCLUSION AND FUTURE WORK 
In this study, a support vector-based (SV-based) predictive model is used to predict the 
associations among cell-mediated activities and multivariate antibody features in RV144 data 
set. Antibody features are filtered out using USFSMs in order to obtain attributes of high 
efficacy. This data set consists of 20 placebo samples and 80 vaccine injected samples, for a 
total of 100 data samples. Cross-validated SV-based predictive models presented higher 
accuracy than in the original study [1].  
The RV144 data set is used to test the predictive capability of the pro- posed KBFS 
model for the given data set and to provide better generalisation and performance compared to 
a study conducted on the same data set [1].  
The goal of the study is to disclose associations among antibody features and their 
effector functions. The effector functions can be described as actions of the immune system to 
fight against HIV. Therefore, the identification of specific antibody features involved in fighting 
against HIV is crucial in neutralising the virus.  
Experimental results conducted on RV144 Vaccine data set suggest that the proposed 
KBFS method, outperforms the state-of-the-art USFSMs as well as the method used in the 
previous paper on the same data set. KBFS has a better quantitative accuracy performance than 
the predictive models constructed using Lars, GP and SVR presented in the data set paper for 
ADCC, and ADCP assays. KBFS has a little less quantitative performance as compared to 
predictive model for Cytokine assay constructed using SVR presented in the data set paper. 
However, it still has better quantitative performance than the Lars and GP predictive models 
for the Cytokine assay. By utilising KBFS framework, the number of features are reduced to 
11 for ADCC assay, 12 for ADCP assay and 16 for Cytokine assay. However, in data set paper, 
the number of selected features are not indicated; instead, filtered set is mentioned without 
providing the number of selected features.  
Experimental results conclude that the proposed unsupervised framework, KBFS, 
achieves generally the best performance on all assays, which thus verifies that it is able to reveal 
discriminative antibody features that provide protection against HIV.  
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